Your browser doesn't support javascript.
A high CMV-specific T cell response associates with SARS-CoV-2-specific IL-17 T cell production.
Frozza, Fernanda Tereza Bovi; Fazolo, Tiago; de Souza, Priscila Oliveira; Lima, Karina; da Fontoura, Julia Crispim; Borba, Théo Souza; Polese-Bonatto, Márcia; Kern, Luciane Beatriz; Stein, Renato T; Pawelec, Graham; Bonorino, Cristina.
  • Frozza FTB; Basic Health Sciences Department, Federal University of Health Sciences of Porto Alegre (UFCSPA), Immunotherapy Laboratory-UFCSPA, R. Sarmento Leite, 245-Centro Histórico, Porto Alegre, 90050-170, Brazil. fernandabfrozza@gmail.com.
  • Fazolo T; Basic Health Sciences Department, Federal University of Health Sciences of Porto Alegre (UFCSPA), Immunotherapy Laboratory-UFCSPA, R. Sarmento Leite, 245-Centro Histórico, Porto Alegre, 90050-170, Brazil.
  • de Souza PO; Basic Health Sciences Department, Federal University of Health Sciences of Porto Alegre (UFCSPA), Immunotherapy Laboratory-UFCSPA, R. Sarmento Leite, 245-Centro Histórico, Porto Alegre, 90050-170, Brazil.
  • Lima K; Basic Health Sciences Department, Federal University of Health Sciences of Porto Alegre (UFCSPA), Immunotherapy Laboratory-UFCSPA, R. Sarmento Leite, 245-Centro Histórico, Porto Alegre, 90050-170, Brazil.
  • da Fontoura JC; Basic Health Sciences Department, Federal University of Health Sciences of Porto Alegre (UFCSPA), Immunotherapy Laboratory-UFCSPA, R. Sarmento Leite, 245-Centro Histórico, Porto Alegre, 90050-170, Brazil.
  • Borba TS; Basic Health Sciences Department, Federal University of Health Sciences of Porto Alegre (UFCSPA), Immunotherapy Laboratory-UFCSPA, R. Sarmento Leite, 245-Centro Histórico, Porto Alegre, 90050-170, Brazil.
  • Polese-Bonatto M; Social Responsibility-PROADI-SUS, Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul, Brazil.
  • Kern LB; Social Responsibility-PROADI-SUS, Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul, Brazil.
  • Stein RT; Social Responsibility-PROADI-SUS, Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul, Brazil.
  • Pawelec G; Escola de Medicina, Pontifícia Universidade Católica Do Rio Grande Do Sul - PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil.
  • Bonorino C; Department of Immunology, University of Tübingen, Tübingen, Germany.
Med Microbiol Immunol ; 212(1): 75-91, 2023 Feb.
Article in English | MEDLINE | ID: covidwho-2259680
ABSTRACT
Human cytomegalovirus (CMV) is a widespread persistent herpes virus requiring lifelong immune surveillance to maintain latency. Such long-term interactions with the immune system may be associated with deleterious effects including immune exhaustion and senescence. Regarding the COVID-19 pandemic, we asked whether CMV-specific cellular and humoral activity could influence immune responses toward SARS-CoV-2 and/or disease severity. All adults with mild (n = 15) and severe (n = 14) COVID-19 were seropositive for anti-CMV IgG, but negative for IgM antibodies. Antibody titers did not correlate with COVID-19 severity. Six patients presented elevated frequencies of CMV-specific CD4 + and CD8 + T cells producing IFNγ, IL-17, and TNFα, designated as CMV high responders (hiT CMV). In comparison to low CMV responders, hiT CMV individuals exhibited higher frequencies of SARS-CoV-2-specific CD4 + IL-17 + and CD8 + IFNγ + , IL-17 + or TNFα + T cells. These results indicate that high frequencies of CMV-specific T cells may be associated with a SARS-CoV-2-reactive profile skewed toward Th17-dominated immunity.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cytomegalovirus Infections / COVID-19 Type of study: Prognostic study Limits: Adult / Humans Language: English Journal: Med Microbiol Immunol Year: 2023 Document Type: Article Affiliation country: S00430-022-00758-1

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Cytomegalovirus Infections / COVID-19 Type of study: Prognostic study Limits: Adult / Humans Language: English Journal: Med Microbiol Immunol Year: 2023 Document Type: Article Affiliation country: S00430-022-00758-1